vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $30.3M, roughly 1.4× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -227.5%, a 214.6% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs -9.5%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs -7.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
GRAL vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $30.3M |
| Net Profit | $-99.2M | $-3.9M |
| Gross Margin | — | 4.6% |
| Operating Margin | -285.4% | -10.9% |
| Net Margin | -227.5% | -12.9% |
| Revenue YoY | 14.0% | -9.5% |
| Net Profit YoY | -2.2% | -2992.6% |
| EPS (diluted) | $-2.37 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $30.3M | ||
| Q3 25 | $36.2M | $28.7M | ||
| Q2 25 | $35.5M | $31.4M | ||
| Q1 25 | $31.8M | $29.5M | ||
| Q4 24 | $38.3M | $33.4M | ||
| Q3 24 | $28.7M | $35.7M | ||
| Q2 24 | $32.0M | $35.5M | ||
| Q1 24 | $26.7M | $35.6M |
| Q4 25 | $-99.2M | $-3.9M | ||
| Q3 25 | $-89.0M | $517.0K | ||
| Q2 25 | $-114.0M | $-2.1M | ||
| Q1 25 | $-106.2M | $-899.0K | ||
| Q4 24 | $-97.1M | $135.0K | ||
| Q3 24 | $-125.7M | $390.0K | ||
| Q2 24 | $-1.6B | $16.0K | ||
| Q1 24 | $-218.9M | $-2.2M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | 8.1% |
| Q4 25 | -285.4% | -10.9% | ||
| Q3 25 | -346.2% | -6.1% | ||
| Q2 25 | -446.9% | -4.6% | ||
| Q1 25 | -482.5% | -0.4% | ||
| Q4 24 | -358.0% | 3.9% | ||
| Q3 24 | -640.5% | 4.8% | ||
| Q2 24 | -5133.8% | 3.6% | ||
| Q1 24 | -851.1% | -3.9% |
| Q4 25 | -227.5% | -12.9% | ||
| Q3 25 | -245.8% | 1.8% | ||
| Q2 25 | -320.7% | -6.5% | ||
| Q1 25 | -333.6% | -3.0% | ||
| Q4 24 | -253.8% | 0.4% | ||
| Q3 24 | -438.7% | 1.1% | ||
| Q2 24 | -4958.8% | 0.0% | ||
| Q1 24 | -819.3% | -6.2% |
| Q4 25 | $-2.37 | $-0.17 | ||
| Q3 25 | $-2.46 | $0.02 | ||
| Q2 25 | $-3.18 | $-0.09 | ||
| Q1 25 | $-3.10 | $-0.04 | ||
| Q4 24 | $-1.49 | $0.00 | ||
| Q3 24 | $-3.94 | $0.02 | ||
| Q2 24 | $-51.06 | $0.00 | ||
| Q1 24 | $-7.05 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $17.8M |
| Total Assets | $2.9B | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | — | ||
| Q3 25 | $126.9M | — | ||
| Q2 25 | $127.4M | — | ||
| Q1 25 | $133.9M | — | ||
| Q4 24 | $214.2M | — | ||
| Q3 24 | $853.6M | — | ||
| Q2 24 | $958.8M | — | ||
| Q1 24 | $199.7M | — |
| Q4 25 | $2.6B | $17.8M | ||
| Q3 25 | $2.2B | $20.0M | ||
| Q2 25 | $2.3B | $18.7M | ||
| Q1 25 | $2.4B | $19.0M | ||
| Q4 24 | $2.5B | $19.6M | ||
| Q3 24 | $2.6B | $18.2M | ||
| Q2 24 | $2.7B | $19.0M | ||
| Q1 24 | — | $20.8M |
| Q4 25 | $2.9B | $107.8M | ||
| Q3 25 | $2.6B | $112.5M | ||
| Q2 25 | $2.7B | $105.8M | ||
| Q1 25 | $2.8B | $110.2M | ||
| Q4 24 | $3.0B | $119.4M | ||
| Q3 24 | $3.1B | $121.6M | ||
| Q2 24 | $3.3B | $124.2M | ||
| Q1 24 | — | $129.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $-1.1M |
| Free Cash FlowOCF − Capex | $-63.9M | $-1.5M |
| FCF MarginFCF / Revenue | -146.5% | -5.0% |
| Capex IntensityCapex / Revenue | 0.2% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $-1.1M | ||
| Q3 25 | $-63.2M | $-178.0K | ||
| Q2 25 | $-77.0M | $1.1M | ||
| Q1 25 | $-95.0M | $-5.5M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $-104.6M | $-4.8M | ||
| Q2 24 | $-171.8M | $6.2M | ||
| Q1 24 | $-207.3M | $-1.7M |
| Q4 25 | $-63.9M | $-1.5M | ||
| Q3 25 | $-63.6M | $-390.0K | ||
| Q2 25 | $-77.3M | $941.0K | ||
| Q1 25 | $-95.1M | $-5.5M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-105.6M | $-4.9M | ||
| Q2 24 | $-173.2M | $6.0M | ||
| Q1 24 | $-209.8M | $-2.0M |
| Q4 25 | -146.5% | -5.0% | ||
| Q3 25 | -175.8% | -1.4% | ||
| Q2 25 | -217.6% | 3.0% | ||
| Q1 25 | -298.6% | -18.8% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | -368.4% | -13.8% | ||
| Q2 24 | -541.7% | 16.8% | ||
| Q1 24 | -785.3% | -5.7% |
| Q4 25 | 0.2% | 1.3% | ||
| Q3 25 | 1.1% | 0.7% | ||
| Q2 25 | 1.0% | 0.5% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | 3.4% | 0.4% | ||
| Q2 24 | 4.3% | 0.5% | ||
| Q1 24 | 9.5% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
